- Report
- June 2026
- 351 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 377 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 131 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 308 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 198 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 323 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 198 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 171 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- July 2025
- 350 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- July 2025
- 350 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- June 2025
- 400 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- June 2025
- 400 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- March 2026
- 144 Pages
Global
From €3565EUR$3,999USD£3,082GBP
- Report
- February 2026
- 141 Pages
Global
From €3565EUR$3,999USD£3,082GBP
- Report
- October 2025
- 137 Pages
Global
From €3565EUR$3,999USD£3,082GBP
- Report
- September 2025
- 149 Pages
Global
From €3565EUR$3,999USD£3,082GBP
- Report
- July 2025
- 350 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- January 2026
- 147 Pages
Global
From €3521EUR$3,950USD£3,045GBP
- Report
- September 2025
- 150 Pages
Global
From €3967EUR$4,450USD£3,430GBP
- Report
- June 2025
- 207 Pages
Global
From €4453EUR$4,995USD£3,850GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more